Comprehensive NGS tumor profiling panel for all solid tumors
NGS tumor profiling panel for non-small cell lung cancer
NGS tumor profiling panel for colorectal cancer
PD-L1/PD-1,and MMR for solid tumors
ASCO 2019 | 24 Research Projects from Genecast Selected
Entitled “Caring for Every Patient, Learning from Every Patient”, ASCO 2019 will be held in Chicag...
HalioDx Signs an Exclusive Agreement with Genecast to Make Immunoscore® Available in China
HalioDx SAS, an immuno-oncology company pioneering the immunological diagnosis of cancers, today a...
Genecast Biotechnology Passed with Full Score 2018 NCCL EQA on the Detection of Somatic Mutation in Cancer
The National Center for Clinical Laboratories (NCCL) released the 2018 National Clinical Laborator...
Genecast Biotechnology Accredited by America’s CAP
Genecast’s Headquarters Laboratory (hereinafter referred to as “Genecast Lab”) recently underw...
Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China
Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology ...